120 results on '"Kuschyk, Juergen"'
Search Results
2. Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry
3. Cardiac contractility modulation in heart failure with reduced ejection fraction patients with QRS duration 120–149 ms: Reduction in heart failure hospitalizations and improvement in functional outcome
4. Long-Term Performance of Subcutaneous Implantable Defibrillators in Athletes: A Multicenter, Real-World Analysis of Sport Activities from the iSUSI Registry
5. Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study
6. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator
7. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry
8. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial
9. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy
10. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator
11. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: An Analysis of All Appropriate Therapy in the PRAETORIAN trial
12. Gender differences of patients treated with wearable cardioverter-defibrillator
13. Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease.
14. Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease
15. Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention (PCI)—Results of the FERARI study
16. Characteristics and long-term outcome of right ventricular involvement in Takotsubo cardiomyopathy
17. Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients
18. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy
19. Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
20. Lebensrettender Schock durch einen subkutanen ICD während eines Fallschirmsprungs
21. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
22. The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest
23. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
24. The Development of the Extravascular Defibrillator with Substernal Lead Placement: A New Frontier for Device-Based Treatment of Sudden Cardiac Arrest
25. Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study
26. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm
27. Prevention of inappropriate ICD shocks in patients with Brugada syndrome
28. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients—A pilot study
29. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators
30. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure
31. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges
32. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome
33. Cardiovascular Response to a Modern Roller Coaster Ride
34. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification
35. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing
36. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry The EFFORTLESS Study
37. Sex differences of in-hospital outcome and long-term mortality in patients with Takotsubo cardiomyopathy
38. Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
39. Sex differences of in-hospital outcome and long-term mortality in patients with Takotsubo cardiomyopathy
40. “Diabetes paradox” in Takotsubo Cardiomyopathy
41. Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary Prevention
42. Comparison of Ventricular Tachyarrhythmia Characteristics in Patients With Idiopathic Dilated or Ischemic Cardiomyopathy and Defibrillators Implanted for Primary Prevention
43. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure
44. Prevention of inappropriate ICD shocks in patients with Brugada syndrome
45. Significant lower proportion of female patients in a multicentre-study collective of patients with prophylactic implatation of an ICD vs. collectives of secondary prevention. Are women less intensively screened?
46. Incidence of patients at high risk of sudden death among patients referred for the suspicion of a brugada-syndrome: a prospective study in 35 consecutive patients with Brugada-like ECG changes
47. Abstract 13862: Appropriate Therapy in the Subcutaneous and Transvenous ICD: A Secondary Analysis of the PRAETORIAN Trial
48. Abstract 13768: Gender Differences in ICD-Related Complications in the PRAETORIAN Trial
49. Long-Term Renal Function with Cardiac Contractility Modulation Therapy.
50. AB22-2: Ajmaline challenge in patients suspicious of Brugada syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.